July auto sales: SML Mahindra sales rise 12%, Escorts Kubota records 22% growth
SML Mahindra, Escorts Kubota see double-digit sales growth in July. Automakers report strong demand for commercial vehicles, farm equipment.
admin
Dr Reddy’s gets US FDA approval for rituximab biosimilar; Fresenius Kabi to commercialise product
Dr Reddy’s received US FDA approval for its rituximab biosimilar, expanding its US market presence. Fresenius Kabi will commercialize it.
Markets Espresso: The Dharam Sankat of Kevin Warsh and is the K-drama finally over?
Kevin Warsh is walking on a tightrope just two policies in. Not a position anyone wants to be in when you’re new to the job.The KOSPI K-Drama had another plot twist this week.Two stocks that defined the “Form is temporary,…
Mahindra & Mahindra July numbers: SUV volumes grow 20% to 60,048 units, total sales up 26%
Mahindra & Mahindra reported 26% overall auto sales growth in July 2026, selling 1,03,860 vehicles. Utility vehicle sales rose 20%, commercial vehicles 23%, and exports 47%.
Hyundai Motor India clocks highest-ever monthly sales in July at 75,360 units
Hyundai Motor India reported record sales in July 2026, with total volumes up 25.4% to 75,360 units. Domestic sales rose 23.3%, exports 31.4%.
SEBI closes proceedings against Religare, Rashmi Saluja over Burman open offer
SEBI has concluded proceedings initiated in 2024 against Religare Enterprises, its former Executive Chairperson Rashmi Saluja and five others, saying no further regulatory directions are required as the Burman Group’s open offer and takeover have already been completed. The regulator…
Raymond Lifestyle Q1 loss widens to ₹23 crore as revenue up 6%; garmenting biz jumps 50%
Shares of Raymond Lifestyle Ltd ended at ₹709.60, down by ₹23.10, or 3.15%, on the BSE.
Lupin gets USFDA approval for Diazepam Injection targeting $78 million US market
Shares of Lupin Ltd ended at ₹2,418.30, down by ₹0.80, or 0.033%, on the BSE.
This business is quietly powering Ram Ratna Wires’ profit surge
Ram Ratna Wires reported a strong June quarter, with net profit more than doubling and revenue rising nearly 89% year-on-year. Growth was driven by robust demand across key industries, higher operating margins and the increasing contribution of its copper tubes…
Why Sun Pharma believes its 80%-plus gross margin is sustainable despite US generics pressure
The drugmaker says a shift towards specialty medicines and branded generics has structurally improved its profitability, even as competition intensifies in the US generics business.